From Innovation to Clinical Adoption: What MedTech Startups Need to Get Right
Developing an innovative medical technology is only one part of bringing a successful product to market. The next challenge is turning that innovation into something clinicians, healthcare organizations, investors, and other stakeholders understand, value, and ultimately adopt.
Medvance Marketing Managing Director Tad Hartlaub recently joined the Signal & Insights podcast by Crowd Answers to discuss some of the biggest commercialization challenges facing emerging MedTech companies today.
Is There Really a Market for Your Innovation?
A promising technology does not automatically mean there is a strong commercial opportunity.
In the podcast, Tad discusses why market-fit analysis is so important for early-stage companies—and why founders need to look beyond whether a product works to understand who needs it, who influences adoption, and what will motivate the market to change.
How do you know whether the opportunity is large enough? Who is the true decision-maker? And what barriers could stand between innovation and adoption?
The full conversation explores the questions companies should be asking before investing heavily in commercialization.
Why Is Clinical Adoption So Complex?
Healthcare products often have to resonate with multiple audiences at once.
Clinicians may care about outcomes and workflow. Administrators may focus on efficiency and financial impact. Procurement teams, payers, investors, and other stakeholders may each evaluate value differently.
That means successful MedTech marketing requires more than communicating product features. Companies need to understand what matters to each audience and why they should change from what they are doing today.
Tad shares how emerging companies can begin thinking more strategically about stakeholder needs, positioning, and messaging.
When Should Marketing Enter the Picture?
Marketing is often treated as something that happens close to launch. But many of the decisions that determine commercialization success need to happen much earlier.
Market research, competitive positioning, value-proposition development, stakeholder insights, and go-to-market planning can all help companies identify opportunities—and potential barriers—before significant resources are committed.
The podcast explores why bringing a commercialization mindset into the process earlier can make a meaningful difference.
Do You Need a Full In-House Marketing Team?
For startups and emerging companies, building an experienced internal marketing department may not always make sense.
Tad also discusses the role of a fractional marketing model and how companies can access specialized strategy, creative, digital, research, and commercialization expertise as their needs evolve.
For growing MedTech organizations, that flexibility can help match marketing resources to the stage of the business without building a large team too early.
Who Should Watch?
This podcast conversation is especially relevant for:
MedTech founders and startup leadership teams
Early-stage companies evaluating product-market fit
Medical device teams preparing for commercialization
Marketing and commercialization leaders
Incubators, accelerators, and investors supporting healthcare innovation
Watch the Full Conversation
What does it really take to move from an innovative idea to meaningful market and clinical adoption?
In the full Signal & Insights episode, Tad dives deeper into market fit, stakeholder communication, commercialization strategy, and the role marketing can play in helping emerging MedTech companies move forward.